한글목차

세계의 Drug Discovery 서비스 시장은 2018년에 99억 2,330만 달러로 평가되어 CAGR 10.0% 이상으로 2023년까지 성장했습니다.

의약품 연구개발(R&D)에 대한 투자의 증가

연구개발에 대한 제약기업의 투자 증가는 지난 기간 중 Drug Discovery 서비스 시장의 성장을 주도했습니다. 제약회사들은 기술 혁신과 의료 격차 해소를 위해 연구개발(R&D)에 많은 투자를 했습니다. 제약 지출 증가는 연구 역량, 첨단 기술 및 광범위한 임상시험에 힘을 실어주었습니다. 이러한 투자로 인해 새로운 치료법과 혁신적 치료법에 대한 관심이 높아지면서 전문 Drug Discovery 서비스에 대한 수요가 증가했습니다. 전임상 및 임상시험 지원은 투자를 구체적인 의학 발전으로 전환하는 데 중요한 역할을 했습니다. 예를 들어 미국 제약업계 기업을 대표하는 미국 제약산업협회(PhRMA)가 실시한 2022년 회원 연례조사에 따르면 2021년 제약업계 회원사들은 연구개발에 1,023억 달러를 투자해 사상 최고치를 기록했으며, 2022년 조사에서는 매출액의 약 20%를 연구개발에 투자한 것으로 나타났습니다. 2022년 조사에 따르면 미국 제약회사들은 매출액의 약 20%를 연구개발에 투자하고 있으며, 2020년 미국 제약업계 전체가 연구개발에 지출한 1,222억 달러의 대부분을 차지합니다. 또한 2022년에는 전 세계 제약회사 전체가 연구개발에 1,390억 달러를 지출합니다. 따라서 의약품 연구개발에 대한 투자 증가는 Drug Discovery 서비스 시장의 성장을 지원하고 있습니다.

목차

제1장 개요

• Drug Discovery 서비스 - 시장의 매력과 거시경제 상황

제2장 목차

제3장 표 리스트

제4장 도표 리스트

제5장 리포트 구성

제6장 시장의 특징

• 일반 시장 정의
• 개요
• Drug Discovery 서비스 시장 정의와 세분화
• 시장 세분화 : 유형별
  • 화학 서비스
  • 생물학 서비스
• 시장 세분화 : 프로세스별
  • 타깃 선택
  • 타깃 검증
  • 리드 제너레이션 식별
  • 리드 최적화
  • 후보자 검증
  • 기타 프로세스
• 시장 세분화 : 약제 유형별
  • 생물학적 제제
  • 저분자 의약품
• 시장 세분화 : 최종사용자별
  • 제약 및 바이오테크놀러지 기업
  • 학술기관
  • 기타 최종사용자

제7장 주요 시장 동향

• 보다 신속하고 효율적인 Drug Discovery를 위한 AI 구동형 툴의 통합
• Drug Discovery에 혁명을 초래하는 첨단 로봇과 자동화 기술
• 최첨단 계산 기술로 의약품 개발을 변혁
• 바이오테크놀러지 산업의 강화를 향한 종합적 Drug Discovery 솔루션
• 주요 기업 간 전략적 파트너십과 협업
• Drug Discovery, 의료 기술, 디지털 헬스를 추진하는 생성형 AI 마이크로서비스의 시작

제8장 Drug Discovery 서비스 시장 : 거시경제 시나리오

• COVID-19의 영향 : Drug Discovery 서비스 시장
• 우크라이나 전쟁의 영향 : Drug Discovery 서비스 시장
• 고인플레이션의 영향 : Drug Discovery 서비스 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 성장 촉진요인, 2018-2023
  • 시장 성장 억제요인, 2018-2023
• 시장 성장 예측, 2023-2028, 2033F
  • 시장 성장 촉진요인, 2023-2028
  • 시장 성장 억제요인, 2023-2028

제10장 세계의 Drug Discovery 서비스 시장 : 세분화

• 세계의 Drug Discovery 서비스 시장 : 유형별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 Drug Discovery 서비스 시장 : 약제 유형별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 Drug Discovery 서비스 시장 : 프로세스별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 Drug Discovery 서비스 시장 : 최종사용자별, 실적과 예측, 2018-2023, 2028F, 2033F

제11장 Drug Discovery 서비스 시장 : 지역·국가별 분석

• 세계의 Drug Discovery 서비스 시장 : 지역별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 Drug Discovery 서비스 시장 : 국가별, 실적과 예측, 2018-2023, 2028F, 2033F

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• 기업 개요
• Charles River Laboratories International, Inc
• Thermo Fisher Scientific Inc
• Laboratory Corporation of America Holdings(Labcorp)
• Evotec SE
• Eurofins Scientific SE
• Selvita S.A.
• Proteros Biostructures GmbH
• Axxam S.p.A
• Enamine Ltd

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 합병과 인수

• Selvita Acquired PozLab
• Ampersand Biomedicines Acquired AbCheck
• Recursion Pharmaceuticals Acquired Cyclica And Valence
• Eurofins Discovery Acquired CALIXAR
• Sygnature Discovery Acquired SB Drug Discovery
• Charles River Laboratories International Acquired SAMDI Tech
• Verseon Acquired Edammo
• ZS Acquired Intomics A/S
• Bayer Acquired Vividion Therapeutics
• X-Chem Acquired IntelliSyn And AviSyn

제23장 기회와 전략

• 세계의 Drug Discovery 서비스 시장, 2028 : 새로운 기회를 제공하는 국가
• 세계의 Drug Discovery 서비스 시장, 2028 : 새로운 기회를 제공하는 부문
• 세계의 Drug Discovery 서비스 시장, 2028 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제24장 Drug Discovery 서비스 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제25장 부록

영문목차

Drug discovery services refer to the range of activities and expertise provided by specialized companies to assist pharmaceutical and biotechnology firms in discovering new drugs. Drug discovery services are essential in the pharmaceutical industry, focusing on the early stages of drug development to identify and validate potential drug candidates.

The drug discovery services market consists of sales, by entities (organizations, sole traders and partnerships), of drug discovery services that encompass various scientific and technical services aimed at accelerating the discovery process, enhancing efficiency and reducing costs for drug developers.

The global drug discovery services market was valued at $9,923.30 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 10.0%.

Increased Investments In Pharmaceutical Research And Development (R&D)

The increased investments in pharmaceutical spending on research and development drove the growth of the drug discovery services market during the historic period. Pharmaceutical firms invested significantly in research and development (R&D) to innovate and address medical gaps. Increased pharmaceutical spending boosted research capabilities, advanced technologies and extensive clinical trials. This investment drove a focus on novel therapies and innovative treatments, raising demand for specialized drug discovery services. Preclinical testing and clinical trial support played a vital role in converting investment into tangible medical advancements. For example, according to the 2022-member annual survey conducted by Pharmaceutical Research and Manufacturers of America (PhRMA), a US-based trade group representing companies in the pharmaceutical industry, PhRMA member companies set a record by investing $102.3 billion in R&D in 2021, marking the highest level of investment ever. The 2022 survey revealed that approximately 20% of their revenue was dedicated to R&D. PhRMA members' spending constitutes the majority of the $122.2 billion spent by the entire US biopharmaceutical industry on R&D in 2020. Additionally, the global pharmaceutical companies collectively spent $139 billion on research and development in 2022. Therefore, the increased investments in pharmaceutical research and development supported the growth of the drug discovery services market.

Advanced Robotic And Automation Technologies For Revolutionizing Drug Discovery

Players in the drug discovery services market are leveraging advanced robotics and automation technologies to enhance efficiency and precision. These innovations streamline target identification, compound screening and lead optimization. High-throughput screening accelerates compound testing, while automated systems ensure accurate synthesis and purification. This integration reduces development time and costs, fostering the discovery of innovative therapeutics. For example, in January 2023, Insilico Medicine, a Hong Kong-based biotechnology company that provides drug discovery services, launched its 6th generation Intelligent Robotics Lab in Suzhou, China, to expedite its AI-driven drug discovery process. The lab employs advanced robotics and automation to streamline drug discovery stages, spanning from target identification to lead optimization. It features automated, high-throughput screening for rapid compound testing against drug targets and robotic systems for compound synthesis and purification, facilitating the creation of novel drug candidates.

The global drug discovery services market is concentrated, with large players operating in the market. The top ten competitors in the market made up 32.9% of the total market in 2023.

Drug Discovery Services Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drug discovery services market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for drug discovery services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drug discovery services market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider drug discovery services market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by process, by drug type and by end user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the drug discovery services market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by process, by drug type and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for drug discovery services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Chemistry Services; Biology Services
• 2) By Process: Target Selection; Target Validation; Hit-To-Lead Identification; Lead Optimization; Candidate Validation; Other Processes
• 3) By End User: Pharmaceutical; Biotechnology Companies; Academic Institutes; Other End Users
• 4) By Drug Type: Biologics Drug; Small Molecule Drug
• Companies Mentioned: Charles River Laboratories International, Inc.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Evotec SE; Eurofins Scientific SE
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drug discovery services indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Drug Discovery Services - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Drug Discovery Services Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Chemistry Services
  • 6.4.2 Biology Services
• 6.5 Market Segmentation By Process
  • 6.5.1 Target Selection
  • 6.5.2 Target Validation
  • 6.5.3 Hit-To-Lead Identification
  • 6.5.4 Lead Optimization
  • 6.5.5 Candidate Validation
  • 6.5.6 Other Processes
• 6.6 Market Segmentation By Drug Type
  • 6.6.1 Biologics Drug
  • 6.6.2 Small Molecule Drug
• 6.7 Market Segmentation By End User
  • 6.7.1 Pharmaceutical And Biotechnology Companies
  • 6.7.2 Academic Institutes
  • 6.7.3 Other End Users

7 Major Market Trends

• 7.1 Integration Of AI-Driven Tools For Faster And More Efficient Drug Discovery
• 7.2 Advanced Robotic And Automation Technologies For Revolutionizing Drug Discovery
• 7.3 Transforming Drug Development With Cutting-Edge Computational Technologies
• 7.4 Comprehensive Drug Discovery Solutions For Enhanced Biotech Industry Support
• 7.5 Strategic Partnerships And Collaborations Among Major Players
• 7.6 Launch Of Generative AI Microservices To Advance Drug Discovery, Medtech And Digital Health

8 Drug Discovery Services Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Drug Discovery Services Market
• 8.2 Impact Of The War In Ukraine On The Drug Discovery Services Market
• 8.3 Impact Of High Inflation On The Drug Discovery Services Market

9 Global Market Size And Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Drug Discovery Services Market Segmentation

• 10.1 Global Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Drug Discovery Services Market, Segmentation By Drug Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.4 Global Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Drug Discovery Services Market, Regional and Country Analysis

• 11.1 Global Drug Discovery Services Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Drug Discovery Services Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Drug Discovery Services Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Drug Discovery Services Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Drug Discovery Services Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 199
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Drug Discovery Services Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 212
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.3 Regulatory Bodies
  • 15.7.7 Major Associations
  • 15.7.8 Taxes Levied
  • 15.7.9 Corporate Tax Structure
  • 15.7.10 Investments
  • 15.7.11 Major Companies
• 15.8 USA Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 231
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Drug Discovery Services Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 263
  • 18.1.3 263
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Charles River Laboratories International, Inc
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Thermo Fisher Scientific Inc
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Laboratory Corporation of America Holdings (Labcorp)
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Evotec SE
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Eurofins Scientific SE
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview
• 19.6 Selvita S.A.
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview
• 19.7 Proteros Biostructures GmbH
  • 19.7.1 Company Overview
  • 19.7.2 Products And Services
  • 19.7.3 Business Strategy
  • 19.7.4 Financial Overview
• 19.8 Axxam S.p.A
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
  • 19.8.3 Business Strategy
  • 19.8.4 Financial Overview
• 19.9 Enamine Ltd
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
  • 19.9.3 Business Strategy
  • 19.9.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Selvita Acquired PozLab
• 22.2 Ampersand Biomedicines Acquired AbCheck
• 22.3 Recursion Pharmaceuticals Acquired Cyclica And Valence
• 22.4 Eurofins Discovery Acquired CALIXAR
• 22.5 Sygnature Discovery Acquired SB Drug Discovery
• 22.6 Charles River Laboratories International Acquired SAMDI Tech
• 22.7 Verseon Acquired Edammo
• 22.8 ZS Acquired Intomics A/S
• 22.9 Bayer Acquired Vividion Therapeutics
• 22.10 X-Chem Acquired IntelliSyn And AviSyn

23 Opportunities And Strategies

• 23.1 Global Drug Discovery Services Market In 2028 - Countries Offering Most New Opportunities
• 23.2 Global Drug Discovery Services Market In 2028 - Segments Offering Most New Opportunities
• 23.3 Global Drug Discovery Services Market In 2028 - Growth Strategies
  • 23.3.1 Market Trend Based Strategies
  • 23.3.2 Competitor Strategies

24 Drug Discovery Services Market, Conclusions And Recommendations

• 24.1 Conclusions
• 24.2 Recommendations
  • 24.2.1 Product
  • 24.2.2 Place
  • 24.2.3 Price
  • 24.2.4 Promotion
  • 24.2.5 People

25 Appendix

• 25.1 Geographies Covered
• 25.2 Market Data Sources
• 25.3 Research Methodology
• 25.4 Currencies
• 25.5 The Business Research Company
• 25.6 Copyright and Disclaimer